相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility
C. Eller-Vainicher et al.
JOURNAL OF DIABETES RESEARCH (2020)
Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes
Nicola Napoli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling
Krasimir Kostov
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice
Steef Kurstjens et al.
SCIENTIFIC REPORTS (2019)
Parathyroid Hormone Signaling in Osteocytes
Marc N. Wein
JBMR PLUS (2018)
Determinants of hypomagnesemia in patients with type 2 diabetes mellitus
Steef Kurstjens et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Mechanisms of diabetes mellitus-induced bone fragility
Nicola Napoli et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis
Katrine Hygum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Parathyroid hormone regulates fates of murine osteoblast precursors in vivo
Deepak H. Balani et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate
Yi Fan et al.
CELL METABOLISM (2017)
Biochemical bone turnover markers in diabetes mellitus - A systematic review
Jakob Starup-Linde et al.
BONE (2016)
Differences in biochemical bone markers by diabetes type and the impact of glucose
Jakob Starup-Linde et al.
BONE (2016)
Management of Hypoparathyroidism: Summary Statement and Guidelines
Maria Luisa Brandi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions
Mishaela R. Rubin et al.
BONE RESEARCH (2016)
Magnesium and type 2 diabetes
Mario Barbagallo et al.
WORLD JOURNAL OF DIABETES (2015)
In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
Joshua N. Farr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
Maria E. Rodriguez-Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Biochemical markers of bone turnover in diabetes patients-a meta-analysis, and a methodological study on the effects of glucose on bone markers
J. Starup-Linde et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Serum levels of bone resorption markers are decreased in patients with type 2 diabetes
Rebeca Reyes-Garcia et al.
ACTA DIABETOLOGICA (2013)
Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes
Mohammed-Salleh M. Ardawi et al.
BONE (2013)
Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
A Prospective Study of Weight Training and Risk of Type 2 Diabetes Mellitus in Men
Anders Grontved et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Decreased PTH Levels Accompanied by Low Bone Formation Are Associated with Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Osteogenic Precursor Cells in Type 2 Diabetes Mellitus
J. S. Manavalan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Bone structure and turnover in type 2 diabetes mellitus
A. Shu et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin A randomized, 52-week, double-blind, active-controlled noninferiority trial
Michael A. Nauck et al.
DIABETES CARE (2011)
Determinants of Serum Sclerostin in Healthy Pre- and Postmenopausal Women
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Faryal S. Mirza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Bone health in diabetes: considerations for clinical management
Silvano Adami
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus
Ippei Kanazawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
High D(+)glucose concentration inhibits RANKL-induced osteoclastogenesis
Y. Wittrant et al.
BONE (2008)
Type 2 diabetes mellitus in nursing home patients:: Effects on bone turnover, bone mass, and fracture risk
Harald Dobnig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Risk of fracture in women with type 2 diabetes: The Women's Health Initiative Observational Study
Denise E. Bonds et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk
P Vestergaard et al.
DIABETOLOGIA (2005)
Older women with diabetes have a higher risk of falls
AV Schwartz et al.
DIABETES CARE (2002)
Magnesium and the parathyroid
T Vetter et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
